Hormone replacement therapy and cancer risk
Matsushita, H.; Wakatsuki, A.
Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 805-809
2012
ISSN/ISBN: 0047-1852 PMID: 23156354 Document Number: 663459
Document emailed within 1 workday
Related Documents
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R. 2001: Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
Birch-Johansen, F.; Jensen, A.; Olesen, A.B.; Christensen, J.; Tjønneland, A.; Kjær, S.K. 2012: Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes and Control: Ccc 23(2): 379-388
Genazzani, A.; Gambacciani, M.; Simoncini, T.; Anniverno, R.; Becorpi, A.M.; Biglia, N.; Brandi, M.L.; Guaschino, S.; Lello, S.; Massobrio, M.; Melis, G.B.; Mencacci, C.; Modena, M.G.; Nappi, C.; Nappi, R.E.; Pecorelli, S.; Petraglia, F.; Rosano, G.M.; Serra, G.B.; Sismondi, P.; Taddei, S.; Tonelli, F. 2007: Italian position statement on hormone replacement therapy following the National Conference on Menopause and Hormone Replacement Therapy, Villa Tuscolana, Frascati (Rome), May 8-9, 2007 Gynecological endocrinology: the official journal of the International Society of Gynecological Endocrinology 23(8): 436-444
Brändstedt, J.; Wangefjord, S.; Nodin, Börn.; Eberhard, J.; Jirström, K.; Manjer, J. 2014: Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability Bmc Cancer 14: 371
Garnier, L.F.; Bourges, O. 2000: Vascular risk and menopause: role of hormone replacement therapy Presse Medicale 29(18): 1013-1018
Simon, T.; Jaillon, P. 2001: Hormone replacement therapy and cardiovascular risk in menopausal women Archives des Maladies du Coeur et des Vaisseaux 94(2): 132-138
Löfqvist, H.; Rylander, E. 2014: Hormone replacement therapy in menopause--risk of disreputable activities Lakartidningen 111(38): 1585
Baber, R.J.; Studd, J.W. 1989: Hormone replacement therapy and cancer British Journal of Hospital Medicine 41(2): 142; 144-146; 148-149
Yonei, Y.; Takahashi, Y.; Hibino, S. 2007: Hormone replacement Up-to-date. Hormone replacement therapy in anti-aging medicine Clinical Calcium 17(9): 1400-1406
Collet, P. 2002: Hormone replacement therapy for menopause: continue or stop the prescription after 10 years? Should hormone replacement therapy be continued after 10 years? of course not! Gynecologie Obstetrique and Fertilite 30(9): 736-739
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Nozaki, H.; Funahashi, H.; Sato, Y.; Imai, T.; Oike, E.; Kato, M.; Takagi, H. 1991: Study of hormone replacement therapy following total thyroidectomy in thyroid cancer--with special reference to the analysis of thyroid hormone peripheral effects, using indirect calorimetry Nihon Geka Gakkai Zasshi 92(12): 1700-1707
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Kuttenn, F.; Gerson, M.; de Lignères, B. 2002: Effects of hormone replacement therapy in menopause on cardiovascular risk. Need for a European study Presse Medicale 31(10): 468-475
Labriola, D.; Pratt, K.; Bufi, P. 2009: 'Natural' hormone replacement and breast cancer risk: evidence for safety and efficacy Oncology 23(7): 639-641
Zhang, Y. 2002: Further recognize the benefit and risk of postmenopausal hormone replacement therapy on atherosclerotic cardiovascular diseases Zhonghua Fu Chan Ke Za Zhi 37(6): 321-323
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530